Pharmacotherapies in Development for Diabetic Macular Edema

Author(s)/Faculty: Quan Dong Nguyen, MD, MSc
Release Date: 6/15/2016Expiration Date: 6/14/2018
Credit Type: CMENumber of Credits: 0.25
Content Type: LectureProvider: Vindico Medical Education
Diabetic retinopathy is especially challenging because it is generally asymptomatic, even as the vision-threatening disease process progresses. Anti-VEGF agents have been established as effective treatment options diabetic macular edema (DME). This CME activity discusses the latest developments in pharmacotherapy for DME.